120 related articles for article (PubMed ID: 38833439)
21. Frequency of endometriosis and adenomyosis in patients with leiomyomas, gynecologic premalignant, and malignant neoplasias.
Nomelini RS; Ferreira FA; Borges RC; Adad SJ; Murta EF
Clin Exp Obstet Gynecol; 2013; 40(1):40-4. PubMed ID: 23724504
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patients.
Rothmund R; Kurth RR; Lukasinski NM; Huebner M; Hartkopf A; Wallwiener M; Staebler A; Brucker SY; Taran FA
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):358-61. PubMed ID: 24176540
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of cellular leiomyoma and partially cellular leiomyoma in postoperative samples - analysis of 384 cases.
Sikora-Szczęśniak DL
Ginekol Pol; 2016; 87(9):609-616. PubMed ID: 27723066
[TBL] [Abstract][Full Text] [Related]
24. Assessment of total effective xenoestrogen burden in adipose tissue and identification of chemicals responsible for the combined estrogenic effect.
Fernández MF; Rivas A; Olea-Serrano F; Cerrillo I; Molina-Molina JM; Araque P; Martínez-Vidal JL; Olea N
Anal Bioanal Chem; 2004 May; 379(1):163-70. PubMed ID: 15024544
[TBL] [Abstract][Full Text] [Related]
25. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
Takeuchi H; Kobori H; Kikuchi I; Sato Y; Mitsuhashi N
J Obstet Gynaecol Res; 2000 Oct; 26(5):325-31. PubMed ID: 11147718
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for adenomyosis in patients with symptomatic uterine leiomyomas.
Romanek K; Bartuzi A; Bogusiewicz M; Rechberger T
Ginekol Pol; 2010 Sep; 81(9):678-80. PubMed ID: 20968175
[TBL] [Abstract][Full Text] [Related]
27. Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma.
Walker CL
Recent Prog Horm Res; 2002; 57():277-94. PubMed ID: 12017548
[TBL] [Abstract][Full Text] [Related]
28. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
Zullo F; Venturella R; Raffone A; Saccone G
Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of endometriosis among patients with adenomyosis and/or myoma uteri scheduled for a hysterectomy.
Naphatthalung W; Cheewadhanaraks S
J Med Assoc Thai; 2012 Sep; 95(9):1136-40. PubMed ID: 23140029
[TBL] [Abstract][Full Text] [Related]
30. Coexistence of endometriosis in women with symptomatic leiomyomas.
Huang JQ; Lathi RB; Lemyre M; Rodriguez HE; Nezhat CH; Nezhat C
Fertil Steril; 2010 Jul; 94(2):720-3. PubMed ID: 19393995
[TBL] [Abstract][Full Text] [Related]
31. Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas.
Shaik NA; Govindan S; Kodati V; Rao KP; Hasan Q
Hematol Oncol Stem Cell Ther; 2009; 2(1):289-93. PubMed ID: 20063560
[TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
34. The assessment of the relationship between the vascularity of FIGO Type 4-7 leiomyomas and abnormal uterine bleeding.
Gursoy AY; Cakmak D; Akgul G; Kiseli M; Umudum H; Pabuccu R; Caglar GS
J Obstet Gynaecol; 2022 Jan; 42(1):153-157. PubMed ID: 33938365
[TBL] [Abstract][Full Text] [Related]
35. Leiomyomatous uterus and preterm birth: an exposed/unexposed monocentric cohort study.
Girault A; Le Ray C; Chapron C; Goffinet F; Marcellin L
Am J Obstet Gynecol; 2018 Oct; 219(4):410.e1-410.e7. PubMed ID: 30153432
[TBL] [Abstract][Full Text] [Related]
36. Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer.
Harris HR; Peres LC; Johnson CE; Guertin KA; Beeghly A; Bandera EV; Bethea TN; Joslin CE; Wu AH; Moorman PG; Ochs-Balcom HM; Petrick JL; Setiawan VW; Rosenberg L; Schildkraut JM; Myers E
Obstet Gynecol; 2023 Jun; 141(6):1124-1138. PubMed ID: 37159277
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas.
Reed SD; Cushing-Haugen KL; Daling JR; Scholes D; Schwartz SM
Menopause; 2004; 11(2):214-22. PubMed ID: 15021452
[TBL] [Abstract][Full Text] [Related]
38. Urine, peritoneal fluid and omental fat proteomes of reproductive age women: Endometriosis-related changes and associations with endocrine disrupting chemicals.
Williams KE; Miroshnychenko O; Johansen EB; Niles RK; Sundaram R; Kannan K; Albertolle M; Zhou Y; Prasad N; Drake PM; Giudice LC; Hall SC; Witkowska HE; Buck Louis GM; Fisher SJ
J Proteomics; 2015 Jan; 113():194-205. PubMed ID: 25284053
[TBL] [Abstract][Full Text] [Related]
39. Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy.
Äyräväinen A; Pasanen A; Ahvenainen T; Heikkinen T; Pakarinen P; Härkki P; Vahteristo P
Hum Reprod; 2020 Oct; 35(10):2237-2244. PubMed ID: 32829387
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer risk and the combined effect of environmental estrogens.
Ibarluzea Jm Jm; Fernández MF; Santa-Marina L; Olea-Serrano MF; Rivas AM; Aurrekoetxea JJ; Expósito J; Lorenzo M; Torné P; Villalobos M; Pedraza V; Sasco AJ; Olea N
Cancer Causes Control; 2004 Aug; 15(6):591-600. PubMed ID: 15280638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
